Milestone Pharmaceuticals Inc(NASDAQ:MIST) 
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the Uni...
Website: http://www.milestonepharma.com
Full Time Employees: 28
CEO: Joseph G. Oliveto
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.72
H 0.73
L 0.67
C 0.70
V 2,781,167
10EMA 0.70
20EMA 0.70
60EMA 0.70
120EMA 0.70
250EMA 0.70